Compare Becton Dickinson and Co (BDX) vs International Business Machines Corp (IBM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs International Business Machines Corp — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $48.93B), while International Business Machines Corp trades at $237.15 (market cap $222.64B). The key difference: International Business Machines Corp is far larger — about 4.6× Becton Dickinson and Co's market cap, and International Business Machines Corp pays the higher dividend (2.86%). Which is the better fit depends on your goals.
| BDX | IBM | |
|---|---|---|
Market Cap | $48.93B | $222.64B |
Sector | Health | Technology |
52-Week High | $185.39 | $329.23 |
52-Week Low | $138.62 | $205.77 |
Enterprise Value | $65.03B | $279.78B |
Dividend Yield | 2.34% | 2.86% |
Volume | — | 4,481,527 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.
The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.
IBM trades at $237.28, up 1.65% today, with a mixed technical outlook showing bullish overall signals but bearish momentum indicators. Recent earnings beat expectations in Q1 2026, though Q2 2026 matched estimates, and revenue growth accelerated to $67.54 billion in 2025. The company maintains strong profitability with a net income margin of 15.52% and a dividend yield of approximately 2.8%, supported by positive cash flow from operations of $13.19 billion.
The stock offers a balanced risk-reward profile, with a consensus price target of $257.38 implying 8.5% upside, but faces headwinds from a securities fraud investigation and competitive pressures in AI. Long-term growth hinges on quantum computing and hybrid cloud adoption, yet near-term volatility may persist due to legal uncertainties and macroeconomic factors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About International Business Machines Corp
International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.
Read more on IBM →
